Companies / BOC Sciences / Vibostolimab
BOC Sciences

Vibostolimab | BOC Sciences

Vibostolimab is an anti-TIGIT monoclonal antibody with antitumor activity. Vibostolimab has been investigated as a monotherapy for advanced solid tumors such as non-small-cell lung cancer (NSCLC).

Reviews


No reviews yet

ABOUT THE COMPANY

BOC Sciences specializes in small molecule synthesis, biosynthesis, purification, and characterization. It provides a wide range of research chemicals and biochemicals, including inhibitors, building blocks, carbohydrates, nucleosides, nucleotides, GMP Products, impurities and metabolites, APIs, natural compounds, ADCs, stem cell molecules and chiral compounds.